Yemaachi Biotech Limited

Based in Accra, Ghana, and founded in 2020, Yemaachi Biotech Limited is a cancer research and diagnostics company that provides solutions to detect and treat cancer in its early stages. In March 2022, Yemaachi Biotech Limited raised USD 3 million in Seed funding from V8 Ventures including Lifeline Financial Group, LoftyInc Capital Management, Tencent Investment, VestedWorld, VSquare Capital, and Y Combinator. David Hutchful, Joyce Ngoi, Yaw Attua-Afari, and Yaw Bediako (CEO) are the co-founders of the company. The company's diagnostics include a COVID-19 testing laboratory and a PanaBIOS trusted testing center, which provides drive-up testing and in-residence testing.

The Sheba HPV Test is a self-sampling kit that includes molecular diagnostic testing for cervical cancer in the company's HeFRA-certified laboratory. Yemaachi partners with pharmaceutical and biotechnology companies to develop the next generation of molecular diagnostics and therapeutics that overcome the challenges of genetic variations. The company's services also include NGS-based screening and prognostic testing. The organization plans to use the March 2022 funds to diversify genomic datasets and advance precision Oncology globally.